| 000 | 01718cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030946.0 | ||
| 008 | 140326s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.22.Ph.D.2013.Sh.R | ||
| 100 | 0 | _aSherien Mohamad Ahmad Mahdy | |
| 245 | 1 | 0 |
_aRole of 18F-FDG PET/CT scan in evaluation of primary and secondary extra-nodal lymphoma / _cSherien Mohamad Ahmad Mahdy ; Supervised Waleed Omar , Emad Ezzat , Mostafa Elhaddad |
| 246 | 1 | 5 | _aدور المسح الذرى البوزيترونى فى تقييم السرطان الكيمياوى خارج الغده الليمفاويه الاولى والثانويه |
| 260 |
_aCairo : _bSherien Mohamad Ahmad Mahdy , _c2013 |
||
| 300 |
_a167 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Nuclear Medicine | ||
| 520 | _aPET was more accurate than CT for diagnosing both nodal and extranodal disease . PET resulted in changes in staging in 8% of patients examined for nodal disease and in 16% of patients examined for extranodal disease . PET is more likely to detect otherwise unsuspected organ involvement in the bone marrow than in the liver, spleen, or the digestive tract | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _a18F-FDG | |
| 653 | 4 | _aExtra-nodal lymphoma | |
| 653 | 4 | _aPET | |
| 700 | 0 |
_aEmad Ezzat , _eSupervisor |
|
| 700 | 0 |
_aMostafa Elhaddad , _eSupervisor |
|
| 700 | 0 |
_aWaleed Omar , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c45539 _d45539 |
||